Similar Articles
Deteriorated Systolic Blood Pressure Recovery and Heart Rate Recovery After Graded Exercise in Children With Familial Mediterranean Fever
Havva EVRENGÜL, Selçuk YÜKSEL, Mustafa DOĞAN, Dolunay GÜRSES, Harun EVRENGÜL
DOI: 10.5606/ArchRheumatol.2017.6071
The Influence of Concomitant Disorders on Disease Severity of Familial Mediterranean Fever in Children
Rabia Miray KIŞLA EKİNCİ, Sibel BALCI, Derya UFUK ALTINTAŞ, Mustafa YILMAZ
DOI: 10.5606/ArchRheumatol.2018.6488
Effects of Familial Mediterranean Fever on Cardiac Functions in Adults: A Cross-Sectional Study Based on Speckle Tracking Echocardiography
Hilal ERKEN PAMUKCU, Mehmet DOĞAN, Cem ÖZİŞLER, Hamza SUNMAN, Melih PAMUKCU, Lale DİNÇ ASARCIKLI
DOI: 10.5606/ArchRheumatol.2019.7005
Disease Severity and Genotype Affect Physical Growth in Children With Familial Mediterranean Fever
Rabia Miray KIŞLA EKİNCİ, Sibel BALCI, Eray AKAY, Dilek DOĞRUEL, Derya Ufuk ALTINTAS, Mustafa YILMAZ
DOI: 10.5606/ArchRheumatol.2019.7198
Familial Mediterranean Fever and Multiple Sclerosis Successfully Treated With Interferon Beta-1a: A Case Report
Bilgin ÖZTÜRK
DOI: 10.5606/ArchRheumatol.2019.7249
A Child Diagnosed With Treatment-Resistant Polyarteritis Nodosa: Can the Clinical Diagnosis Be Different?
Demet ALAYGUT, Caner ALPARSLAN, Elif Perihan ÖNCEL, Fatma MUTLUBAŞ, Tunç ÖZDEMİR, Önder YAVAŞCAN, Belde KASAP DEMİR
DOI: 10.5606/ArchRheumatol.2019.7075
Assessment of Circulating Microribonucleic Acids in Patients With Familial Mediterranean Fever
Ferhat DEMİR, Alper Han ÇEBİ, Mukaddes KALYONCU
DOI: 10.5606/ArchRheumatol.2020.7414
The Prevalence of Familial Mediterranean Fever and Behçet’s Disease: A Cross-Sectional Study
Özgür ALPARSLAN, Buğra Han EGELİ, Yeltekin DEMİREL, Serdal UĞURLU
DOI: 10.46497/ArchRheumatol.2020.7769
Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis
Caner Feyzi DEMİR, Ferhat BALGETiR, Özlem ETHEMOĞLU, Dürdane AKSOY, Filiz AKTAŞ, Süleyman Serdar KOCA, Mehmet Fatih YETKIN, İrem TAŞCI
DOI: 10.46497/ArchRheumatol.2021.8229
The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients
Veli Yazısız, Vural Taner Yılmaz, İsmail Uçar, Özgür Dandin, Bengisu Aslan, Funda Erbasan, Hüseyin Koçak, Mustafa Ender Terzioğlu
DOI: 10.46497/ArchRheumatol.2021.8500
Clinical features of children with chronic non-bacterial osteomyelitis: A multicenter retrospective case series from Turkey
Ceyhun Açarı, Elif Çomak, Şükrü Çekiç, Serkan Türkuçar, Hatice Adıgüzel Dündar, Sara Şebnem Kılıç, Sema Akman, Balahan Makay, Şevket Erbil Ünsal
DOI: 10.46497/ArchRheumatol.2021.8137
Differentiating children with familial Mediterranean fever from other recurrent fever syndromes: The utility of new Eurofever/PRINTO classification criteria
Rabia Miray Kışla Ekinci, Sibel Balcı, Ahmet Hakan Erol, Dilek Karagöz, Derya Ufuk Altıntaş, Atıl Bisgin
DOI: 10.46497/ArchRheumatol.2021.8616
Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience
Ferhat Demir, Eda Gürler, Betül Sözeri
DOI: 10.46497/ArchRheumatol.2022.8998
Mevalonate kinase gene polymorphisms in ankylosing spondylitis patients: A cross-sectional study
Fatih Yıldız, Suzan Dinkçi, Eren Erken
DOI: 10.46497/ArchRheumatol.2023.9468
Evaluation of peripheral nerve involvements in patients with familial Mediterranean fever
Atak Karabacak, Rahşan İnan, Nesrin Şen
DOI: 10.46497/ArchRheumatol.2023.9695
New and future perspectives in familial Mediterranean fever and other autoinflammatory diseases
Veysel Çam, Hülya Ercan Emreol, Seza Ozen
DOI: 10.46497/ArchRheumatol.2024.10911
Prevalence and characteristics of juvenile fibromyalgia syndrome in pediatric rheumatic diseases: A comparative study
Gülcan Özomay Baykal, Duygu Kurtuluş, Serap Ata, Betül Sözeri
DOI: 10.46497/ArchRheumatol.2024.10562